US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

0.6779
+0.0878+14.88%

Close Nov 27 16:00 ET

0.6900
+0.0121+1.78%

Post 20:01 ET

70.36MMarket Cap-1473P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Unicycive Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Unicycive Therapeutics Earnings Reports

Unicycive Therapeutics | 8-K: Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

Nov 13 08:07 ET

Unicycive Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 07:08 ET

Unicycive Therapeutics | 8-K: Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update

Aug 14 08:14 ET

Unicycive Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 07:09 ET

Analyst Rating

Updated: Nov 27, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall